Christophe Baralotto and Michel Féraud founded Provepharm with the aim of setting an example in terms of both business and values.
Two "kids" from Marseille, barely out of their teens, had a dream: to build something unique together.
The company built its reputation and, at the same time, launched internal research programs.
One of these concerned a new process for synthesizing methylene blue, which led to the filing of an international patent in 2006. From then on, Provepharm's story accelerated.